Vanguard Group’s TetraLogic Pharmaceuticals TLOG Stock Holding History
Bought
Maintained
Sold
Other funds holding TLOG
Vanguard Group's TLOG Position: Q4 2016 in Review
Vanguard Group sold out of TetraLogic Pharmaceuticals (TLOG) in Q4 2016, closing a stake of 157,349 shares — an estimated $25K sold.
Vanguard Group first reported a position in TLOG in Q3 2014 and held it in 9 quarters. The position peaked at $580K in Q1 2015. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.
- Vanguard Group reported no remaining TetraLogic Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Vanguard Group sold 157,349 TetraLogic Pharmaceuticals shares in Q4 2016, an estimated $25K.
- Vanguard Group first reported a position in TetraLogic Pharmaceuticals in Q3 2014 and held it in 9 quarters.
- Vanguard Group's TetraLogic Pharmaceuticals position peaked at $580K in Q1 2015.
- 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals as of Q4 2016.
Based on Vanguard Group's 13F filing for Q4 2016, filed 14 Feb 2017.